Lencya (Ulipristal Acetate)

Ulipristal acetate acts as a selective progesterone receptor modulator. It binds to progesterone receptors in the ovary, blocking the hormone’s action and thereby inhibiting or delaying the release of an egg (ovulation). In fibroid tissue, the same receptor modulation reduces cell growth and promotes apoptosis, leading to shrinkage of the fibroids.

The dosage of Lencya is determined by the prescribing clinician based on the indication and patient characteristics. For emergency contraception, a single oral dose is typically prescribed, while fibroid management may involve a different regimen. Exact dosing instructions should always be obtained from a qualified healthcare professional.

Lencya is contraindicated in confirmed or suspected pregnancy because its mechanism interferes with normal hormonal processes. Limited data are available on its excretion in breast milk, and the product is generally not recommended for breastfeeding mothers unless the benefits outweigh potential risks as assessed by a physician.

To order Lencya, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The most common alternative for emergency contraception is levonorgestrel, a progestin that must be taken within 72 hours of intercourse. Ulipristal acetate (Lencya) remains effective up to five days and works by directly modulating progesterone receptors, offering a longer window of efficacy and a different mechanism compared with levonorgestrel.

Lencya tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protect them from moisture and direct sunlight, and ensure they are out of reach of children. No refrigeration is required.

Lencya is taken orally as a tablet. The tablet should be swallowed whole with a glass of water. It is usually taken as a single dose for emergency contraception; dosing for fibroid treatment follows the regimen prescribed by the treating physician.

The most serious adverse reactions associated with Lencya include severe allergic responses such as anaphylaxis, significant liver injury indicated by elevated enzymes or hepatitis, and persistent abdominal pain that could signal uterine complications. Patients should seek immediate medical attention if they experience any of these symptoms.

Lencya should not be used by women who are already pregnant, have a known hypersensitivity to ulipristal acetate or any excipients, have severe liver disease, or who are relying on it as a regular contraceptive method. Individuals with uncontrolled hormonal disorders should also discuss suitability with their healthcare provider.